Free Trial
OTCMKTS:TRUMY

Terumo Q4 2026 Earnings Results & Report

Terumo logo
$15.05 0.00 (0.00%)
As of 11/13/2026 03:55 PM Eastern

Terumo met analyst earnings expectations and beat on revenue in its Q4 2026 results, released May 15, 2026. The company reported EPS of $0.11 versus the $0.11 consensus estimate, while revenue of $1.90 billion topped the $1.84 billion estimate by $55.09 million.

Earnings Announcement Details

Quarter
Q4 2026
Report Date
Time
Before Market Opens

Terumo EPS Results

Actual EPS
$0.11
Consensus EPS
$0.11
Beat/Miss
Met Expectations
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 8 quarters

Terumo Revenue Results

Actual Revenue
$1.90 billion
Expected Revenue
$1.84 billion
Beat/Miss
Beat by +$55.09 million
YoY Revenue Growth
N/A

Conference Call Resources

Terumo Q4 2026 Earnings FAQ

Terumo (OTCMKTS:TRUMY) reported earnings of $0.11 per share for Q4 2026, matching the consensus estimate of $0.11. The report was announced on Friday, May 15, 2026.

Terumo reported revenue of $1.90 billion for Q4 2026, against a consensus estimate of $1.84 billion.

Terumo Earnings Headlines

Terumo (OTCMKTS:TRUMY) Shares Gap Down Following Weak Earnings
ELON + YOU + DECEMBER 8TH
Elon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet.tc pixel
Terumo (OTCMKTS:TRUMY) Stock Falls 7.4% Following Weak Earnings
Terumo Corporation (TRUMY) Q2 2027 Earnings Call Transcript
Terumo ADR (TRUMY) Ratios
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services.

Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.

Headquartered in Tokyo, Terumo serves healthcare customers in Japan and markets around the world. Its products support areas including patient care, cardiovascular treatment, transfusion medicine and cell therapy.

View Terumo Profile